title: Cannabis consumption as a prognostic factor in schizophrenia.
abstract: Data were analysed from 62 schizophrenic patients between 18 and 30 years of age, treated at the community mental health centres in Navarra, who had relapsed and then completed a one-year follow-up study. Factors influencing the course of illness during follow-up were: continuing cannabis consumption; previous cannabis intake; non-compliance with treatment; and stress.
authors.affiliation: Alcobendas Mental Health Centre, Madrid, Spain.
authors.forename: M J
authors.initials: MJ
authors.lastname: Martinez-Arevalo
authors.forename: A
authors.initials: A
authors.lastname: Calcedo-Ordoñez
authors.forename: J R
authors.initials: JR
authors.lastname: Varo-Prieto
mesh_terms: D000293:Adolescent; D000328:Adult; D015897:Comorbidity; D013759:Dronabinol / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000453:epidemiology* / Q000523:psychology / Q000534:rehabilitation; D010349:Patient Compliance / Q000523:psychology; D012008:Recurrence; D012559:Schizophrenia / Q000453:epidemiology* / Q000534:rehabilitation; D012565:Schizophrenic Psychology; D013315:Stress, Psychological / Q000150:complications; D016896:Treatment Outcome
chemical_list: D013759:Dronabinol